Logo UE
Copolad
Cooperation Program between
Latin America, the Caribbean and the European Union
on drug policy
No Result
View All Result
Copolad II 2015-2020
  • COPOLAD
    • What is COPOLAD?
    • Context
    • How we work
    • Objectives
    • Participants/Allies
    • Technical team
    • Public Tenders
  • Work Areas
    • National Drug Observatories
    • Demand Reduction
    • Fight against drug trafficking
    • Alternative Development
    • Control of drug precursor chemicals
    • Proportionality and criminal alternatives
    • EU-CELAC dialogue on drug policies
    • Women and Drugs
    • Policy innovation
  • Program Results
  • Knowledge Portal
    • COPOLAD III Meetings
    • Directory of centers and services
    • Library
    • Blog
    • Work groups
  • Comunication
    • News
    • Albums
    • Videos
    • Press releases
    • COPOLAD in media
  • English
    • Español
  • COPOLAD
    • What is COPOLAD?
    • Context
    • How we work
    • Objectives
    • Participants/Allies
    • Technical team
    • Public Tenders
  • Work Areas
    • National Drug Observatories
    • Demand Reduction
    • Fight against drug trafficking
    • Alternative Development
    • Control of drug precursor chemicals
    • Proportionality and criminal alternatives
    • EU-CELAC dialogue on drug policies
    • Women and Drugs
    • Policy innovation
  • Program Results
  • Knowledge Portal
    • COPOLAD III Meetings
    • Directory of centers and services
    • Library
    • Blog
    • Work groups
  • Comunication
    • News
    • Albums
    • Videos
    • Press releases
    • COPOLAD in media
  • English
    • Español
No Result
View All Result
Copolad
No Result
View All Result
Home News

EMCDDA becomes official partner of COPOLAD III

The European Observatorie will cooperate through targeted training activities and co-production workshops to develop tailored outputs

22/07/2022
in News, Press releases
foto EMCDDA

foto EMCDDA

Compartir en FacebookCompartir en TwitterCompartir en Linkedin

The  European Monitoring Center for Drugs and Drug Abbuse (EMCDDA) becomes an official partner of COPOLAD III,  a programme promoting dialogue and bi-regional cooperation on drug policy between the European Union and Latin American and Caribbean countries (LAC). Funded by the EU, the programme is led by the International Ibero-American Foundation for Public Policies and Administrations (FIIAPP), in consortium with the Italian-Latin American International Organization (IILA). Collaborating in the programme are the Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH (GIZ) (2) and the EMCDDA.

The programme, which began in February 2021, will run until January 2025 with a total budget of EUR 15 million. The EMCDDA signed a grant agreement with IILA today for EUR 800 000. This paves the way for a range of activities supporting LAC countries through a stronger focus on data collection, evidence-based policies and research.

The agreement (which will run until October 2024), will see the EMCDDA support FIIAPP and the IILA in delivering the following programme outputs:

  • strengthened technical capacity and institutional role of the national drug observatories (NDOs);
  • improved coherence, balance, quality and evidence base of drug demand reduction policies in LAC countries;
  • effective strengthening of cooperation in drug trafficking investigative activities;
  • enhanced support for the political–technical dialogue between EU and LAC regions on drug-related issues.

When delivering the activities, the agency will apply co-production and co-ownership principles and adopt a multiple stakeholder and multi-disciplinary approach. It will also use EMCDDA toolboxes and resources for data collection and analysis. These cover: key epidemiological and market indicators; early-warning system methods; prevention platforms and tools; and health and social responses guides. Methods will be adapted to national circumstances and tools will be translated where necessary.

Activities will address the need to increase national capacity to better use information for policies and action. This will be done through targeted training activities and co-production workshops to develop tailored outputs to support practice configured to local needs.

Initially launched in 2011, COPOLAD aims to identify common priorities and coordinate policies to tackle challenges related to the global drugs problem. The EMCDDA provided ad-hoc support to the first two phases of the project: COPOLAD I (2011–15) and COPOLAD II (2016– 2020).

Tags: emcddaEUDANDOobservatoriesobservatoriosOND

Últimas noticias

Guide for line 171 (option 6)

Life is our answer

Legal pages

  • Legal notice

  • Privacy police

  • Cookies policy

  • Accesibility

Social media

COPOLAD is a consortium formed by:

4.-Version-negativa-color-con-tagline-1024x375
logo iila

Collaborating partners:

logo giz
No Result
View All Result
  • COPOLAD
    • What is COPOLAD?
    • Context
    • How we work
    • Objectives
    • Participants/Allies
    • Technical team
    • Public Tenders
  • Work Areas
    • National Drug Observatories
    • Demand Reduction
    • Fight against drug trafficking
    • Alternative Development
    • Control of drug precursor chemicals
    • Proportionality and criminal alternatives
    • EU-CELAC dialogue on drug policies
    • Women and Drugs
    • Policy innovation
  • Program Results
  • Knowledge Portal
    • COPOLAD III Meetings
    • Directory of centers and services
    • Library
    • Blog
    • Work groups
  • Comunication
    • News
    • Albums
    • Videos
    • Press releases
    • COPOLAD in media
  • English
    • Español
Copolad II 2015-2020

© COPOLAD. Programa de Cooperación entre América Latina, el Caribe y la Unión Europea en Políticas sobre Drogas.